Atrial Fibrillation Flashcards
Components of CHA2DS2VASc Score
C: Congestive HF
H: HTN
A: Age > 75 years (2 pts)
D: Diabetes
S: Stroke/TIA/Systemic Embolism (2 pts)
V: Vascular Disease
A: 75-74 years
Sc: Female
Anticoagulation indicated in men with a CHA2DS2VASc Score ≥ ___
<p>2</p>
<p>Anticoagulation indicated in women with a CHA2DS2VASc Score ≥ \_\_\_</p>
<p>3</p>
<p>HASBLED Componenets</p>
<p>H: HTN - SBP > 160 mm Hg<br></br>A: Abnormal liver/kidney function (1 each)<br></br>S: Stroke history<br></br>B: Bleeding history<br></br>L: Labile INR</p>
<p>E: Elderly > 65 years</p>
<p>D: Drug/Alcohol abuse (1 each)</p>
<p>Lenient Rate Control HR Goal</p>
<p>< 110 bpm</p>
<p>Patients who qualify for Lenient Rate Control</p>
<p>Asymptomatic <strong>AND </strong>EF > 40%</p>
<p>Strict Rate Control HR Goal</p>
<p>< 80 bpm</p>
<p>Patients who qualify for Strict Rate Control</p>
<p>Symptomatic <strong>OR</strong> EF ≤ 40%</p>
Type of Cardioversion in Hemodynamically Unstable Patient
Immediate DCCV
Typoe of Cardioversion in Symptomatic Patient Desite Rate Control
DCCV, Chemical Cardioversion, or Both
Type of Cardioversion in a Paitnet Unable to Achieve Rate Control
DCCV, Chemical Cardioversion, or Both
Type of Cardioversion in a Paitnet Unable to Achieve Rate Control
DCCV, Chemical Cardioversion, or Both
Vaughan-Williams Class I Anti-arrythmic Class
Sodium Channel Blockade
Vaughan-Williams Class I Anti-arrythmics
Ia: Disopyramide, quinidine, procainamide
1b: Lidoacine, mexiletine
1c: Flecainide, Propafenone
Vaughan-Williams Class II Anti-arrythmics Class
Beta-blockers
